Showing results (61-70 of 116) with videos related to
Sort By:
Pageof 12
American Heart Journal|November 10, 2019
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristicsStefan M Nidorf, Aernoud T L Fiolet, John W Eikelboom, et al.European Heart Journal|May 10, 2026
Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trialPeter van der Meer, Dirk J van Veldhuisen, Geert H D Voordes, et al.Journal of the American Heart Association|May 15, 2025
Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 TrialNiekbachsh Mohammadnia, Britta E Wesselink, Willem A Bax, et al.Plos One|July 16, 2015
No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary SyndromeJudith M Poldervaart, Emma Röttger, Marieke S Dekker, et al.Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Sex differences in flow cytometry-based platelet reactivity in stable outpatients suspected of myocardial ischemiaFarahnaz Waissi, Mirthe Dekker, Ingrid E M Bank, et al.Journal of Cardiac Failure|July 3, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes ModelRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.European Heart Journal. Acute Cardiovascular Care|September 25, 2013
Serum extracellular vesicle protein levels are associated with acute coronary syndromeVince C de Hoog, Leo Timmers, Arjan H Schoneveld, et al.Scientific Reports|September 24, 2021
High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndromeMirthe Dekker, Farahnaz Waissi, Max J M Silvis, et al.Journal of Electrocardiology|December 21, 2010
Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCITon Heestermans, Harry Suryapranata, Jurriën M ten Berg, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 9, 2025
2023 European Society of Cardiology guidelines for the management of cardiovascular disease in patients with diabetes : Statement of endorsement by the NVVCFabrice M A C Martens, Frank L J Visseren, Jan Westerink, et al.Pageof 12